- Lobbying
- Lobbying by Juno Therapeutics, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Manus Cooney | Staff Director & Chief Counsel, Senate Judiciary Committee |
Julie Philp | LD, Rep. John Campbell; LA/Senior LA, Rep. Gil Gutknecht; LA and Scheduler, Rep. Michael Burgess; LA, Scheduler, Rep. Connie Morella; LA, Ileana Ros-Lehtinen |
Chris Israel | U.S. Coordinator for International IP Enforcement; Deputy Chief of Staff, Department of Commerce; Deputy Assistant Secretary for Tech Policy, Department of Commerce |
Stephen Pinkos | Policy Dir/Gen Counsel, House Majority Whip Kevin McCarthy; Deputy Undersecretary of Commerce for IP; Staff Director, House Judiciary Committee |
Mary O'Dea Ahearn | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
White House Office
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
White House Office
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: Innovation and investment issues impacting Juno Therapeutics..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate